Shohei Tsuchihashi
Kyoto, 6068501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Improving Pharmacokinetics of PSMA/GRPR-Targeting Radiolabeled Heterodimer through Enhanced Albumin Binding.
Journal: Molecular pharmaceutics
Published: July 14, 2026
Systematic Investigation of Fatty Acids with Different Carbon-Chain Length as Albumin Binder to Improve Tumor Accumulation of Radioligands.
Journal: Bioconjugate chemistry
Published: June 23, 2026
Preclinical evaluation of novel 177Lu-labeled fibroblast activation protein inhibitor with albumin binder for radioligand therapy.
Journal: Annals of nuclear medicine
Published: November 10, 2025
Development of Novel Gastrin-Releasing Peptide Receptor-Targeted Radioligand with Albumin Binder to Improve Accumulation in Tumor.
Journal: ACS medicinal chemistry letters
Published: January 15, 2025
Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders.
Journal: Nuclear medicine and biology
Published: April 20, 2024
Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands.
Journal: Annals of nuclear medicine
Published: March 06, 2024
Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation.
Journal: Nuclear medicine and biology
Published: January 19, 2024
Development of Novel 111In/225Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics.
Journal: Journal of medicinal chemistry
Published: June 07, 2023
Synthesis and Evaluation of Novel 111In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform.
Journal: Molecular pharmaceutics
Published: June 27, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026